These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1145 related articles for article (PubMed ID: 17021388)

  • 21. Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    J Pharmacol Exp Ther; 1997 Nov; 283(2):794-9. PubMed ID: 9353400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted rats.
    Visanji NP; Millan MJ; Brotchie JM
    Exp Neurol; 2006 Nov; 202(1):85-92. PubMed ID: 16814282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.
    Basso AM; Gallagher KB; Bratcher NA; Brioni JD; Moreland RB; Hsieh GC; Drescher K; Fox GB; Decker MW; Rueter LE
    Neuropsychopharmacology; 2005 Jul; 30(7):1257-68. PubMed ID: 15688083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
    Sheppard B; Lehmann J; Cope ZA; Brown RW
    Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACTH 4-9 analogue facilitates the antiimmobility effect of antidepressants and dopamine agonists in swimming rats.
    Zebrowska-Lupina I; Pietrasiewicz T; Ossowska G; Lupina T; Klenk-Majewska B
    J Physiol Pharmacol; 1997 Jun; 48(2):263-75. PubMed ID: 9223030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
    Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
    Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
    Dekeyne A; Brocco M; Loiseau F; Gobert A; Rivet JM; Di Cara B; Cremers TI; Flik G; Fone KC; Watson DJ; Papp M; Sharp T; Serres F; Cespuglio R; Olivier B; Chan JS; Lavielle G; Millan MJ
    J Pharmacol Exp Ther; 2012 Mar; 340(3):765-80. PubMed ID: 22178753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
    Hirano S; Miyata S; Onodera K; Kamei J
    Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of dopamine D2 receptor in the behavioral effects of imipramine--study with the use of antisense oligonucleotides.
    Dziedzicka-Wasylewska M; Kolasiewicz W; Rogóz Z; Margas W; Maj J
    J Physiol Pharmacol; 2000 Sep; 51(3):401-9. PubMed ID: 11016860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists.
    Loiseau F; Millan MJ
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):23-33. PubMed ID: 18793829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
    Rogoz R; Dziedzicka-Wasylewska M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease.
    Jones CA; Johnston LC; Jackson MJ; Smith LA; van Scharrenburg G; Rose S; Jenner PG; McCreary AC
    Eur Neuropsychopharmacol; 2010 Aug; 20(8):582-93. PubMed ID: 20434890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
    Biała G
    Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
    Gulwadi AG; Korpinen CD; Mailman RB; Nichols DE; Sit SY; Taber MT
    J Pharmacol Exp Ther; 2001 Feb; 296(2):338-44. PubMed ID: 11160615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J; Dougherty JJ; Nichols RA
    J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral profile of quinpirole in agonistic encounters between male mice.
    Navarro JF; Maldonado E
    Methods Find Exp Clin Pharmacol; 1999 Sep; 21(7):477-80. PubMed ID: 10544391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.